Baptist Cancer Center - Memphis — Memphis, Tennessee

Baptist Cancer Center - Memphis is a clinical research site located in Memphis, Tennessee, United States 38120.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Baptist Cancer Center - Memphis has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baptist Cancer Center - Memphis?

Baptist Cancer Center - Memphis has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baptist Cancer Center - Memphis conducted?

Baptist Cancer Center - Memphis has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.

Is Baptist Cancer Center - Memphis accredited by Crixeo Health?

Baptist Cancer Center - Memphis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baptist Cancer Center - Memphis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.